12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Medigene, Will-Pharma sales and marketing update

Medigene said Will-Pharma launched Veregen sinecatechins in the Netherlands to treat genital warts. In 2011, Will-Pharma received exclusive marketing rights to Veregen in Belgium, the Netherlands...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >